CSJ just launched a joint supplement called Shift, sourced from what the company calls Europe's largest manufacturer of nutritional supplements. The ingredient list, MSM, glucosamine HCI, chondroitin sulphate, UCII collagen, hyaluronic acid, vitamin C, reads like the back panel of the premium joint SKUs already sitting on your shelf.
The repeated move you're watching
We're seeing pet brands use European co-packers to launch supplement lines that mirror retail formulas. CSJ's Ceri Rundle said the company "worked again" with the same manufacturer, which means this is a playbook, not a one-off.
The pattern: brands are using contract manufacturing to build supplement lines that compete on ingredient claims. What changes the competitive math is whether the manufacturing relationship translates into a wholesale offer that undercuts your current assortment.
Shift comes in 150g resealable packs. One pack should last a month for a medium-sized dog (10-25kg), the company said. CSJ hasn't announced pricing or distribution strategy.
What the pattern predicts
If CSJ moves into independent distribution, it competes directly with your existing joint-supplement margin leaders. The ingredient stack, glucosamine, chondroitin, MSM, plus UCII collagen and hyaluronic acid, is what premium joint formulas already carry. What we don't know yet is whether CSJ's manufacturing relationship gives it pricing room to undercut your shelf.
Brands that launch supplements through contract manufacturers can sometimes offer wholesale pricing that squeezes retail margin. That shows up in the margin you're offered when the rep calls.
If your supplement assortment runs on margin leaders that look like this formula, subscribe to PetRetailNews.
What would prove us wrong
CSJ stays direct-only and never pitches wholesale. Or it pitches wholesale at pricing that respects your existing shelf margin, treating retail as a premium channel rather than a volume play. Both are possible, we're watching to see which one happens.
The thing to watch next
Whether CSJ's rep calls you in the next 90 days with a wholesale offer, and what the margin looks like when they do. If the pricing undercuts your current joint-supplement assortment at equivalent ingredient claims, that's the signal the pattern is live in your market. If it doesn't, CSJ is treating retail as a different business, and this launch stays in the direct channel where it started.
The ingredient list tells you nothing new. The distribution decision tells you everything.